pyrrolidine dithiocarbamate has been researched along with rifampin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byrne, ST; Chong, C; Denkin, SM; Gu, P; Liu, JO; Sullivan, D; Zhang, Y; Zhou, J | 1 |
| He, X; Song, Y; Wang, L; Xu, J | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and rifampin
| Article | Year |
|---|---|
Pyrrolidine dithiocarbamate and diethyldithiocarbamate are active against growing and nongrowing persister Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Ditiocarb; Female; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Pyrrolidines; Rifampin; Thiocarbamates | 2007 |
Protective effect of pyrrolidine dithiocarbamate on isoniazid/rifampicin‑induced liver injury in rats.
Topics: Animals; Antioxidants; ATP Binding Cassette Transporter, Subfamily B, Member 11; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Humans; Isoniazid; Liver; NF-kappa B; Oxidative Stress; Pyrrolidines; Rats; Rifampin; Thiocarbamates; Tumor Necrosis Factor-alpha | 2020 |